Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)

Clinical trial NCT07036003 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07036003
Sponsor: Dr. David Wasserstein
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Knee Osteoarthritis (Knee OA)Knee Osteoarthritis (OA)

Start date: 2025-10-31
Primary completion: 2028-07-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.